Clinical Trial

Chinese PD Registry

Study acronym: CPDR
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the Chinese Parkinson's disease Registry (CPDR) is to develop a database of patients with Parkinson's disease in China.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2019-03-21.
Trial Details
NCT Number NCT03887663
Lead Sponsor Xiangya Hospital of Central South University
Conditions Parkinson Disease
Enrollment 3,000 participants
Start Date 2017-02-01
Primary Completion 2027-02-01 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2019-12-13